"10.1371_journal.pone.0003121","plos one","2008-09-01T00:00:00Z","Marta Mastroianni; Kazuo Watanabe; Travis B White; Fanglei Zhuang; Jamie Vernon; Manabu Matsuura; John Wallingford; Alan M Lambowitz","Institute for Cellular and Molecular Biology, University of Texas at Austin, Austin, Texas, United States of America","Conceived and designed the experiments: MM KW TBW FZ JV MM JW AML. Performed the experiments: MM KW TBW FZ JV MM. Analyzed the data: MM KW TBW FZ JV MM AML. Wrote the paper: AML. Comments and revisions: JW MM JV FZ TBW KW MM.","Group II intron gene targeting technology is subject to U.S. and foreign patents and patent applications licensed by the Ohio State University and the University of Texas at Austin to InGex, LLC. A.M.L. is a minority equity holder in InGex, LLC. A.M.L. and other authors may receive royalty payments for commercial use of the technology.","2008","09","Marta Mastroianni","MM",8,TRUE,7,5,6,1,TRUE,TRUE,FALSE,0,NA,FALSE
